• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植后胱氨酸病中的胰腺内分泌功能不全

Pancreatic endocrine insufficiency in posttransplant cystinosis.

作者信息

Fivush B, Green O C, Porter C C, Balfe J W, O'Regan S, Gahl W A

出版信息

Am J Dis Child. 1987 Oct;141(10):1087-9. doi: 10.1001/archpedi.1987.04460100065027.

DOI:10.1001/archpedi.1987.04460100065027
PMID:3307383
Abstract

Nephropathic cystinosis causes renal death by approximately age 10 years. With increased life span due to kidney transplantation, ten to 25 years of cystine accumulation has resulted in pancreatic complications in individuals with cystinosis. We noted severe hyperglycemia in five posttransplant patients, three of whom remained insulin-dependent diabetics several years after transplant. The clinical findings were not consistent with steroid-dependent or insulin-resistant diabetes. Pancreatic cystine deposition was detected histologically and biochemically on post-mortem examination of two other patients. We conclude that hyperglycemia may be anticipated in the immediate posttransplant period in cystinotic patients and that some patients will require insulin therapy years later. The use of cystine-depleting agents should be considered in posttransplant cystinosis as an attempt to prevent potential damage to the pancreas and other organs from cystine deposition.

摘要

肾性胱氨酸病通常会在10岁左右导致肾衰竭死亡。随着肾移植技术的发展延长了患者寿命,患胱氨酸病的个体因10至25年的胱氨酸积累而出现胰腺并发症。我们注意到5例肾移植术后患者出现严重高血糖,其中3例在移植后数年仍依赖胰岛素治疗。临床症状与类固醇依赖型或胰岛素抵抗型糖尿病不符。对另外2例患者进行尸检时,通过组织学和生化方法检测到胰腺中有胱氨酸沉积。我们得出结论,胱氨酸病患者在肾移植术后短期内可能会出现高血糖,部分患者在数年后需要胰岛素治疗。对于肾移植术后的胱氨酸病患者,应考虑使用降低胱氨酸的药物,以防止胱氨酸沉积对胰腺和其他器官造成潜在损害。

相似文献

1
Pancreatic endocrine insufficiency in posttransplant cystinosis.移植后胱氨酸病中的胰腺内分泌功能不全
Am J Dis Child. 1987 Oct;141(10):1087-9. doi: 10.1001/archpedi.1987.04460100065027.
2
Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis.一名患有肾病型胱氨酸病患者的胰腺外分泌功能不全
J Pediatr. 1988 Jan;112(1):49-51. doi: 10.1016/s0022-3476(88)80119-7.
3
Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.半胱胺在肾移植中的应用:两例肾病性胱氨酸病患者的报告及移植后即刻成功重新开始半胱胺治疗
Pediatr Transplant. 2016 Feb;20(1):141-5. doi: 10.1111/petr.12617. Epub 2015 Oct 19.
4
Course of nephropathic cystinosis after age 10 years.10岁后肾病型胱氨酸病的病程
J Pediatr. 1986 Oct;109(4):605-8. doi: 10.1016/s0022-3476(86)80221-9.
5
Swallowing dysfunction in nephropathic cystinosis.肾病性胱氨酸病中的吞咽功能障碍。
N Engl J Med. 1990 Aug 30;323(9):565-70. doi: 10.1056/NEJM199008303230903.
6
Renal transplantation in 22 children with nephropathic cystinosis.22例肾病型胱氨酸病患儿的肾移植
Pediatr Nephrol. 1991 Nov;5(6):708-14. doi: 10.1007/BF00857880.
7
Ocular manifestations of nephropathic cystinosis. The French-Canadian experience in a genetically homogeneous population.肾病性胱氨酸病的眼部表现。法裔加拿大人在基因同质人群中的经验。
Arch Ophthalmol. 1991 Mar;109(3):359-62. doi: 10.1001/archopht.1991.01080030061039.
8
Nephropathic cystinosis associated with cardiomyopathy: a 27-year clinical follow-up.与心肌病相关的肾性胱氨酸病:27年临床随访
BMC Nephrol. 2002 Nov 9;3:8. doi: 10.1186/1471-2369-3-8.
9
Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis.胰岛素分泌和C肽生成的逐渐恶化是婴儿胱氨酸病中糖尿病的特征。
Eur J Pediatr. 1998 Sep;157(9):738-42. doi: 10.1007/s004310050926.
10
Follow-up and treatment of adults with cystinosis in the Netherlands.荷兰成年胱氨酸病患者的随访与治疗
Nephrol Dial Transplant. 2002 Oct;17(10):1766-70. doi: 10.1093/ndt/17.10.1766.

引用本文的文献

1
Long-term outcomes in nephropathic cystinosis: a review.肾性胱氨酸病的长期预后:综述
Pediatr Nephrol. 2025 May 14. doi: 10.1007/s00467-025-06790-6.
2
Programmed Cell Death in Cystinosis.胱氨酸病中的细胞程序性死亡。
Cells. 2022 Feb 15;11(4):670. doi: 10.3390/cells11040670.
3
Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.组织蛋白酶 B 作为胱氨酸贮积症肾病治疗监测的新型生物标志物。
J Am Soc Nephrol. 2020 May;31(5):1092-1106. doi: 10.1681/ASN.2019080774. Epub 2020 Apr 9.
4
Mutation analysis of the gene in Iranian patients with infantile nephropathic cystinosis: identification of two novel mutations.伊朗婴儿型肾病性胱氨酸病患者该基因的突变分析:两种新突变的鉴定
Hum Genome Var. 2017 Oct 5;4:17038. doi: 10.1038/hgv.2017.38. eCollection 2017.
5
First Successful Conception Induced by a Male Cystinosis Patient.首例由男性胱氨酸病患者实现的成功受孕。
JIMD Rep. 2018;38:1-6. doi: 10.1007/8904_2017_19. Epub 2017 Apr 13.
6
Cystinosis: a review.胱氨酸病:综述
Orphanet J Rare Dis. 2016 Apr 22;11:47. doi: 10.1186/s13023-016-0426-y.
7
Cystine accumulation attenuates insulin release from the pancreatic β-cell due to elevated oxidative stress and decreased ATP levels.由于氧化应激升高和三磷酸腺苷(ATP)水平降低,胱氨酸积累会减弱胰腺β细胞释放胰岛素的能力。
J Physiol. 2015 Dec 1;593(23):5167-82. doi: 10.1113/JP271237. Epub 2015 Nov 18.
8
Improving the prognosis of nephropathic cystinosis.改善肾病型胱氨酸病的预后。
Int J Nephrol Renovasc Dis. 2014 Jul 17;7:297-302. doi: 10.2147/IJNRD.S37603. eCollection 2014.
9
New-onset diabetes after kidney transplant in children.儿童肾移植术后新发糖尿病
Pediatr Nephrol. 2015 Mar;30(3):405-16. doi: 10.1007/s00467-014-2830-7. Epub 2014 Jun 4.
10
Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations.胱氨酸病作为一种具有多个突变等位基因的溶酶体贮积病:表型-基因型相关性
World J Nephrol. 2013 Nov 6;2(4):94-102. doi: 10.5527/wjn.v2.i4.94.